
Palisade Bio (PALI) Earnings Dates & Reports
Palisade Bio (PALI) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.29
Actual EPS-$0.38
EarningsMiss
Palisade Bio (PALI) Earnings
View the latest Palisade Bio (PALI) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Palisade Bio (PALI)
Order type
Buy in
Order amount
Est. shares
0 shares
Palisade Bio (PALI) Earnings per Share (EPS) History
Signup for full accessBrowse free
Palisade Bio (PALI) Latest Earnings
The value each PALI share was expected to gain vs. the value each share gained.
Palisade Bio (PALI) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.38. This exceeded analysts' expectations of -$0.29 by 31.03%, marking a Miss.
For comparison, Palisade Bio reported EPS of -$2.32 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.02.
Palisade Bio (PALI) Earnings History
Palisade Bio (PALI) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Palisade Bio’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Palisade Bio (PALI) Earnings FAQs
Palisade Bio (PALI) last reported earnings on Nov 10, 2025 for Q3 2025, posting an EPS of -$0.38, which Miss the estimate of -$0.29 by 31.03%.
For Q3 2025, Palisade Bio (PALI) reported an EPS of -$0.38, missing analysts' estimate of -$0.29 by 31.03%.
For Q3 2025, Palisade Bio (PALI) Miss expectations with an actual EPS of -$0.38 vs. an estimated EPS of -$0.29.
Following the last earnings report on Nov 10, 2025, Palisade Bio (PALI)'s stock price moved — from — to —.
The next Palisade Bio (PALI) earnings call is scheduled for Mar. 23, 2026, where executives will discuss financial results and outlook.